The mechanisms driving relapse in multiple myeloma
Transplantation versus novel therapies in high-risk chronic lymphoblastic leukemia (CLL)?
Round table with Prof. John Gribben and Prof. Stephan Stilgenbauer on CLL
John Gribben et al.
Mohamad Mohty on EBMT 2016
Myeloma XI trial: impact of MRD on treatment response in MM